Antiretroviral News and Research

RSS

Antiretroviral treatment failure due to lack of patient support

A new report to be presented at the Toronto International AIDS Conference shows that access to antiretrovirals is only part of the treatment equation.

15 Aug 2006

Bill Gates says protecting against HIV/AIDS can't be left to men

Microsoft founder Bill Gates says all the money in the world will not conquer HIV/AIDS unless more progress is made in preventing new infections. Gates says women and other high-risk groups must be given the ability to protect themselves.

14 Aug 2006

Adherence by Africans to antiretroviral regimens

More HIV-infected Sub-Saharan Africans took their anti-HIV medications as directed than HIV-infected N. Americans did, according to the largest and most extensive review of adherence studies to date.

8 Aug 2006

AIDS drugs still work but TB a deadly addition to the virus

According to a new report, ten years after they were introduced in Europe and North America, HIV/AIDS drugs remain effective but many patients are not being put on them soon enough.

7 Aug 2006

HIV virus can survive efforts to destroy it by hiding in the mucosal tissues of the intestine

UC Davis researchers have discovered that the human immunodeficiency virus, the virus that causes AIDS, is able to survive efforts to destroy it by hiding out in the mucosal tissues of the intestine.

6 Aug 2006

Providing antiretroviral treatment to workers of large companies in Africa is feasible

Providing antiretroviral treatment to workers of large companies in Africa is feasible, according to the authors of a Viewpoint in this week's issue of The Lancet.

3 Aug 2006

Stopping antiretroviral therapy in HIV-infected patients could be beneficial

Stopping antiretroviral therapy in HIV-infected patients from time to time could reduce the side effects and costs of the treatment, according to a study in this week's issue of The Lancet.

3 Aug 2006

Highly active antiretroviral therapy for HIV remains successful

A decade after the introduction of highly active antiretroviral therapy (HAART) for HIV infection in Europe and North America, the risk of AIDS and death remains low for those starting treatment.

3 Aug 2006

Implications of the new Medicare Part D prescription drug benefit for people with HIV/AIDS

The Kaiser Family Foundation today released a report on the implications of the new Medicare Part D prescription drug benefit for people with HIV/AIDS.

3 Aug 2006

Darunavir - first molecule to treat drug-resistant HIV

Doctors have their first FDA-approved tool to treat drug-resistant HIV thanks to a new molecule created by a Purdue University researcher.

2 Aug 2006

Practical advice and individualized attention can help people with HIV stick to a consistent drug regimen

The studies were too different to combine results, but the review team found that the most successful programs emphasized "practical medicine management," one-on-one attention or a 12-week or longer duration.

2 Aug 2006

HIV mutation clue to why only some people develop AIDS dementia

The study of 18 HIV-positive subjects shows that HIV in the brain and central nervous system is genetically different from HIV that lives in the blood and peripheral tissues.

26 Jul 2006

Going to court to get access to essential medicines should only be used as a last resort

Going to court to get access to essential medicines may be necessary and has been successful in several cases, but it should only be used as a last resort, according to an article in this week's issue of The Lancet.

21 Jul 2006

Highly active antiretroviral therapies associated with reduced infections in HIV-infected children

Since the introduction of highly active antiretroviral therapies, there has been a substantial reduction of opportunistic infections and other infections in HIV-infected children, such as pneumonia and tuberculosis.

19 Jul 2006

Clinton Foundation seals deal in Nigerian AIDS fight

The Clinton Foundation, an AIDS charity set up by former U.S. President Bill Clinton, has signed a deal with Nigeria to make cheap AIDS drugs available to fight the disease in Africa's most populous nation.

18 Jul 2006

FDA approves Atripla three-drug combination tablet for treatment of HIV-1

FDA approves Atripla Tablets, a fixed-dose combination of three widely-used antiretroviral drugs.

12 Jul 2006

3-drug pill will help fight HIV/AIDS

The Food and Drug Administration (FDA) in the U.S. has granted approval for a three-ingredient fixed dose tablet for use as an antiretroviral treatment for human immunodeficiency virus (HIV-1) infection in adults.

3 Jul 2006

FDA gives tentative approval for generic pediatric AIDS drug

The Food and Drug Administration (FDA) today announced the tentative approval of the generic version of Abacavir Sulfate Oral Solution.

27 Jun 2006

FDA approves Prezista (darunavir)

FDA approves Prezista (darunavir), a new drug for adults whose infection with the human immunodeficiency virus (HIV) has not responded to treatment with other antiretroviral drugs.

26 Jun 2006

$21 billion for HIV/AIDS, is it paying off?

This year, the U.S. federal government will spend $21 billion for HIV/AIDS research, treatment, prevention, and related activities. Is this enormous expenditure paying off?

1 Jun 2006